AP-238

AP-238 is a novel opioid compound that was developed recently and has been studied for its potential medical applications. AP-238, a relatively new compound that has only appeared on the research chemical market recently, is not documented as to its creator or specific development time. Its CAS is 180345403-3.

The full chemical name of AP-238 is 1-(4-Fluorobenzyl)-4-methyl-4,9-diazaspiro[5.5]undecan-1-one, and its molecular formula is C17H22FN3O.

In its purest state, AP-238 appears as a powdery white crystalline substance. The appearance of any chemical substance can vary slightly depending on how it was synthesized and purified.

AP-238 belongs to the opioid family, and its chemical structure may have different effects. Opioids have analgesic properties, but some also produce feelings of relaxation and euphoria.

AP-238, a relatively recent substance, is not well-known for its effects or dosage. This substance must be used with extreme caution and in a responsible manner. It is best to start with a small dose to gauge the body’s response to the substance.

In conclusion, AP-238 shows promise for research due to its unique chemistry and position within the opioid family. The unique position it occupies in the market for research chemicals piques curiosity.

Please be aware that you must always comply with local laws and regulations pertaining to the sale, possession, and use of substances such as AP-238. Before using any new substance, consult a healthcare professional or qualified professional. AP-238 contains a powerful compound that should be used with caution. This information is provided for research and educational purposes only and does not constitute any medical advice.